Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Fluvastatin, rhabdomyolysis, and myotoxicity.

Murinson BB, Maragakis NJ, Jacobson TA.

Mayo Clin Proc. 2008 Nov;83(11):1296; author reply 1297. No abstract available.

PMID:
18990330
2.

[Statin-induced rhabdomyolysis and renal failure: also with fluvastatine].

Lado Lado FL, Rodríguez Moreno C, Cinza Sajurjo S, Durán Parrondo C, Pazo Núñez M, Lois Pernas A, Masa Vázquez L.

An Med Interna. 2004 May;21(5):235-7. Spanish.

PMID:
15176926
3.

The HMG Co-A reductase inhibitors ('statins') and myotoxic effects.

[No authors listed]

S Afr Med J. 2002 Aug;92(8):596-7. No abstract available.

PMID:
12244613
4.

Possible colchicine rhabdomyolysis in a fluvastatin-treated patient.

Atasoyu EM, Evrenkaya TR, Solmazgul E.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1368-9. Epub 2005 Jun 14. No abstract available.

PMID:
15956236
5.

[Statin therapy and muscle disorders].

Abel T, Fehér J.

Orv Hetil. 2009 Feb 8;150(6):261-3. doi: 10.1556/OH.2009.28520. Hungarian. No abstract available.

PMID:
19179258
6.

Increases in creatine kinase after exercise in patients treated with HMG Co-A reductase inhibitors.

Thompson PD, Nugent AM, Herbert PN.

JAMA. 1990 Dec 19;264(23):2992. No abstract available.

PMID:
2243421
7.

Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin.

Baek SD, Jang SJ, Park SE, Ok TJ, Leem J, Lee HS, Park SJ, Kim TH.

J Korean Med Sci. 2011 Dec;26(12):1634-7. doi: 10.3346/jkms.2011.26.12.1634. Epub 2011 Nov 29.

8.

Updated clinical safety experience with fluvastatin.

Jokubaitis LA.

Am J Cardiol. 1994 May 26;73(14):18D-24D. Review.

PMID:
8198019
9.

Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient.

Basic-Jukic N, Kes P, Bubic-Filipi L, Vranjican Z.

Nephrol Dial Transplant. 2010 Jun;25(6):2036; author reply 2036-7. doi: 10.1093/ndt/gfq157. Epub 2010 Mar 23. No abstract available.

PMID:
20332417
10.

Fluvastatin: efficacy and safety in reducing cardiac events.

Chan MY, Lee CH.

Expert Opin Pharmacother. 2005 Sep;6(11):1883-95. Review.

PMID:
16144508
11.

Incidence of skeletal muscle disorders after statins' treatment: consequences in clinical and EMG picture.

Drobny M, Pullmann R, Odalos I, Skerenova M, Saniova B.

Neuro Endocrinol Lett. 2014;35(2):123-8.

PMID:
24878976
12.

Fluvastatin and cancer.

Mascitelli L, Pezzetta F.

Int J Clin Pract. 2007 Jan;61(1):168; author reply 168-9. No abstract available.

PMID:
17229191
13.

Lichenoid drug eruption with HMG-CoA reductase inhibitors (fluvastatin and lovastatin).

Sebök B, Tóth M, Anga B, Harangi F, Schneider I.

Acta Derm Venereol. 2004;84(3):229-30. No abstract available.

PMID:
15202842
14.

Fluvastatin-induced rhabdomyolysis.

Modi JR, Cratty MS.

Ann Pharmacother. 2002 Dec;36(12):1870-4.

PMID:
12452746
15.

Autoimmune hepatitis after treatment with fluvastatin.

Castiella A, Fernandez J, Zapata E.

Liver Int. 2007 May;27(4):592. No abstract available.

PMID:
17403199
16.

Nutritional status affects fluvastatin-induced hepatotoxicity and myopathy in rats.

Sugatani J, Sadamitsu S, Kurosawa M, Ikushiro S, Sakaki T, Ikari A, Miwa M.

Drug Metab Dispos. 2010 Oct;38(10):1655-64. doi: 10.1124/dmd.110.034090. Epub 2010 Jun 29.

17.

[High therapeutic effect and safety of fluvastatin].

[No authors listed]

Pharm Unserer Zeit. 2003;32(6):516-7. Review. German. No abstract available.

PMID:
14639833
18.

Muscular adverse effects of statins.

[No authors listed]

Prescrire Int. 2003 Feb;12(63):21. No abstract available.

PMID:
12602397
19.

Rhabdomyolysis induced by co-administration of fluvastatin and colchicine.

Sarullo FM, Americo L, Di Franco A, Di Pasquale P.

Monaldi Arch Chest Dis. 2010 Sep;74(3):147-9.

PMID:
21110512
20.

Severe rhabdomyolysis after laparoscopic surgery for adenocarcinoma of the rectum in two patients treated with statins.

Forestier F, Breton Y, Bonnet E, Janvier G.

Anesthesiology. 2002 Oct;97(4):1019-21. No abstract available.

PMID:
12357176

Supplemental Content

Support Center